Stories
Slash Boxes
Comments

Dev.SN ♥ developers

posted by janrinok on Friday February 28 2014, @08:01PM   Printer-friendly
from the one-should-be-more-than-enough dept.

GungnirSniper writes:

"Pharmaceutical company Zogenix has received US FDA approval to launch a new hydrocodone-based analgesic in March. The drug is intended only for chronic pain, not as an short term or as-needed analgesic. CNN is reporting a coalition of groups are lobbying for the FDA to revoke their approval before the medicine is even available.

The concerns echoed by all groups are broadly about the drug's potency and abuse potential. They say they fear that Zohydro especially at higher doses will amplify already-rising overdose numbers.

'You're talking about a drug that's somewhere in the neighborhood of five times more potent than what we're dealing with now,' said Dr. Stephen Anderson, a Washington emergency room physician who is not part of the most recent petition to the FDA about the drug. 'I'm five times more concerned, solely based on potency.'

A number of other news outlets are hyping the potency of Zohydro, going so far as calling the drug ten times more powerful than a 5mg Vicodan. A fairer comparison may be to OxyCodone, since they have similar opioid levels. Zohydro ER will be available in 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, and 50 mg strengths.

Chemistry Soylents can find the structural formula for hydrocodone bitartrate on RxList.

Should the FDA allow such a potent medication on the market? Or would moving opioid analgesics to Schedule II mitigate the potential for abuse?"

 
This discussion has been archived. No new comments can be posted.
Display Options Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 2) by mrbluze on Saturday March 01 2014, @04:44PM

    by mrbluze (49) on Saturday March 01 2014, @04:44PM (#9223)

    Go ahead have it, but the way the system is run this is just a license to print money for a drug that, if you read the product information, has the same side effect profile as the others. It's a morphine derivative, so allergy to one will give allergy to the other.

    --
    Do it yourself, 'cause no one else will do it yourself.
    Starting Score:    1  point
    Karma-Bonus Modifier   +1  

    Total Score:   2  
  • (Score: 1) by xtronics on Wednesday March 05 2014, @02:56PM

    by xtronics (1884) on Wednesday March 05 2014, @02:56PM (#11462) Homepage

    Not really - they have differing half lives and even slight differences can prevent and or cause side effects.

  • (Score: 1) by xtronics on Wednesday March 05 2014, @03:36PM

    by xtronics (1884) on Wednesday March 05 2014, @03:36PM (#11479) Homepage

    Also - having more choices and suppliers would lower the cost not raise it (remember when we had one choice for long distance? )